Rituximab-including combined modality treatment for primary thyroid lymphoma: An effective regimen for elderly patients (Thyroid (2014) 24, 6 (994-999))

Natsuko Watanabe, Hiroto Narimatsu, Jaeduk Yoshimura Noh, Yo Kunii, Koji Mukasa, Masako Matsumoto, Miho Suzuki, Kenichi Sekiya, Hidemi Ohye, Ai Yoshihara, Kenji Iwaku, Sakiko Kobayashi, Kaori Kameyama, Kazuhiko Kobayashi, Yoshitaka Nishikawa, Masahiro Kami, Kiminori Sugino, Koichi Ito

研究成果: Comment/debate

元の言語English
ページ数1
ジャーナルThyroid
24
発行部数9
DOI
出版物ステータスPublished - 2014 9 1
外部発表Yes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

これを引用

Watanabe, N., Narimatsu, H., Noh, J. Y., Kunii, Y., Mukasa, K., Matsumoto, M., Suzuki, M., Sekiya, K., Ohye, H., Yoshihara, A., Iwaku, K., Kobayashi, S., Kameyama, K., Kobayashi, K., Nishikawa, Y., Kami, M., Sugino, K., & Ito, K. (2014). Rituximab-including combined modality treatment for primary thyroid lymphoma: An effective regimen for elderly patients (Thyroid (2014) 24, 6 (994-999)). Thyroid, 24(9). https://doi.org/10.1089/thy.2013.0523.cxn